NM_001364905.1:c.1513A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001364905.1(LRBA):​c.1513A>G​(p.Ile505Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00106 in 1,606,962 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0059 ( 6 hom., cov: 31)
Exomes 𝑓: 0.00055 ( 8 hom. )

Consequence

LRBA
NM_001364905.1 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.325

Publications

2 publications found
Variant links:
Genes affected
LRBA (HGNC:1742): (LPS responsive beige-like anchor protein) The protein encoded by this gene is a member of the WDL-BEACH-WD (WBW) gene family. Its expression is induced in B cells and macrophages by bacterial lipopolysaccharides (LPS). The encoded protein associates with protein kinase A and may be involved in leading intracellular vesicles to activated receptor complexes, which aids in the secretion and/or membrane deposition of immune effector molecules. Defects in this gene are associated with the disorder common variable immunodeficiency-8 with autoimmunity. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
LRBA Gene-Disease associations (from GenCC):
  • combined immunodeficiency due to LRBA deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0059100688).
BP6
Variant 4-150906386-T-C is Benign according to our data. Variant chr4-150906386-T-C is described in ClinVar as Benign. ClinVar VariationId is 540402.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00587 (894/152316) while in subpopulation AFR AF = 0.0199 (829/41580). AF 95% confidence interval is 0.0188. There are 6 homozygotes in GnomAd4. There are 427 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRBANM_001364905.1 linkc.1513A>G p.Ile505Val missense_variant Exon 12 of 57 ENST00000651943.2 NP_001351834.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRBAENST00000651943.2 linkc.1513A>G p.Ile505Val missense_variant Exon 12 of 57 NM_001364905.1 ENSP00000498582.2 A0A494C1L5

Frequencies

GnomAD3 genomes
AF:
0.00584
AC:
889
AN:
152198
Hom.:
6
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0199
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00321
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00623
GnomAD2 exomes
AF:
0.00146
AC:
365
AN:
249880
AF XY:
0.00113
show subpopulations
Gnomad AFR exome
AF:
0.0205
Gnomad AMR exome
AF:
0.000817
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000177
Gnomad OTH exome
AF:
0.000493
GnomAD4 exome
AF:
0.000553
AC:
805
AN:
1454646
Hom.:
8
Cov.:
28
AF XY:
0.000452
AC XY:
327
AN XY:
723882
show subpopulations
African (AFR)
AF:
0.0192
AC:
641
AN:
33320
American (AMR)
AF:
0.00117
AC:
52
AN:
44538
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26038
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39606
South Asian (SAS)
AF:
0.0000585
AC:
5
AN:
85498
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53354
Middle Eastern (MID)
AF:
0.000522
AC:
3
AN:
5742
European-Non Finnish (NFE)
AF:
0.0000271
AC:
30
AN:
1106422
Other (OTH)
AF:
0.00123
AC:
74
AN:
60128
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
37
74
112
149
186
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00587
AC:
894
AN:
152316
Hom.:
6
Cov.:
31
AF XY:
0.00573
AC XY:
427
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.0199
AC:
829
AN:
41580
American (AMR)
AF:
0.00320
AC:
49
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68020
Other (OTH)
AF:
0.00616
AC:
13
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
46
93
139
186
232
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00291
Hom.:
3
Bravo
AF:
0.00705
ESP6500AA
AF:
0.0195
AC:
86
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00193
AC:
234

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Jul 21, 2020
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Combined immunodeficiency due to LRBA deficiency Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
15
DANN
Benign
0.84
DEOGEN2
Benign
0.034
.;T;.
Eigen
Benign
-0.86
Eigen_PC
Benign
-0.70
FATHMM_MKL
Benign
0.38
N
LIST_S2
Benign
0.50
T;T;T
MetaRNN
Benign
0.0059
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.29
N;N;.
PhyloP100
0.33
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.69
N;N;N
REVEL
Benign
0.025
Sift
Benign
0.29
T;T;T
Sift4G
Benign
0.29
T;T;T
Polyphen
0.0010
B;B;B
Vest4
0.26
MVP
0.38
MPC
0.095
ClinPred
0.0022
T
GERP RS
1.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.024
gMVP
0.14
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35612775; hg19: chr4-151827538; API